Citigroup’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$10K | – | 7837 |
|
|
2020
Q4 | $10K | Hold |
20,000
| – | – | ﹤0.01% | 6969 |
|
|
2020
Q3 | $11K | Sell |
20,000
-7
| -0% | -$5 | ﹤0.01% | 6591 |
|
|
2020
Q2 | $14K | Sell |
20,007
-22,907
| -53% | -$18.4K | ﹤0.01% | 6884 |
|
|
2020
Q1 | $36K | Buy |
42,914
+5,928
| +16% | +$8.47K | ﹤0.01% | 6281 |
|
|
2019
Q4 | $61K | Buy |
36,986
+8,443
| +30% | +$12.7K | ﹤0.01% | 6159 |
|
|
2019
Q3 | $32K | Sell |
28,543
-14,289
| -33% | -$16.5K | ﹤0.01% | 6427 |
|
|
2019
Q2 | $54K | Buy |
42,832
+7,296
| +21% | +$9.29K | ﹤0.01% | 6412 |
|
|
2019
Q1 | $51K | Buy |
35,536
+600
| +2% | +$890 | ﹤0.01% | 6335 |
|
|
2018
Q4 | $41K | Buy |
34,936
+14,893
| +74% | +$22.1K | ﹤0.01% | 6411 |
|
|
2018
Q3 | $27K | Buy |
20,043
+10,305
| +106% | +$16.3K | ﹤0.01% | 6949 |
|
|
2018
Q2 | $22K | Buy |
9,738
+3,942
| +68% | +$7.62K | ﹤0.01% | 6879 |
|
|
2018
Q1 | $8K | Buy |
5,796
+1,189
| +26% | +$1.39K | ﹤0.01% | 7123 |
|
|
2017
Q4 | $3K | Buy |
4,607
+4,491
| +3,872% | +$4.01K | ﹤0.01% | 7354 |
|
|
2017
Q3 | $0 | Buy |
116
+9
| +8% | +$11 | ﹤0.01% | 7541 |
|
|
2017
Q2 | $0 | Sell |
107
-2,243
| -95% | -$4.77K | ﹤0.01% | 7563 |
|
|
2017
Q1 | $6K | Sell |
2,350
-36,749
| -94% | -$132K | ﹤0.01% | 6754 |
|
|
2016
Q4 | $166K | Buy |
39,099
+34,629
| +775% | +$114K | ﹤0.01% | 5440 |
|
|
2016
Q3 | $12K | Sell |
4,470
-700
| -14% | -$1.61K | ﹤0.01% | 6478 |
|
|
2016
Q2 | $9K | Sell |
5,170
-26,286
| -84% | -$53.6K | ﹤0.01% | 6614 |
|
|
2016
Q1 | $73K | Buy |
31,456
+19,021
| +153% | +$43K | ﹤0.01% | 5891 |
|
|
2015
Q4 | $43K | Buy |
12,435
+11,074
| +814% | +$53K | ﹤0.01% | 6050 |
|
|
2015
Q3 | $8K | Sell |
1,361
-484
| -26% | -$3.28K | ﹤0.01% | 6570 |
|
|
2015
Q2 | $12K | Sell |
1,845
-26,626
| -94% | -$180K | ﹤0.01% | 6380 |
|
|
2015
Q1 | $203K | Buy |
+28,471
| New | +$215K | ﹤0.01% | 4518 |
|
Other funds holding GEN
IC
TRCT
Citigroup's GEN Position: Q1 2021 in Review
Citigroup sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 20,000 shares — an estimated $10K sold.
Citigroup first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $203K in Q1 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Citigroup reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Citigroup sold 20,000 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $10K.
- Citigroup first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Citigroup's Genesis Healthcare, Inc. position peaked at $203K in Q1 2015.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.